Want to join the conversation?
$JNJ's unit Janssen Research & Development said the U.S. Food and Drug Administration (FDA) has granted a Breakthrough Therapy Designation for use in combination with standard of care regimens for patients with multiple myeloma. Multiple myeloma is incurable blood cancer that occurs when malignant plasma cells grow uncontrollably in bone marrow.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)